#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, March 28 '26)

 

Antimicrob Agents Chemother

1. ZHOU J, Yan S, Zhao Y, Zhang H, et al
   A phase I study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of suraxavir marboxil: a novel oral antiviral for influenza.
   Antimicrob Agents Chemother. 2026 Mar 23:e0166825. doi: 10.1128/aac.01668.
   PubMed         Abstract available
   
   

   
   Arch Virol

2. KIM S, Kim JW, Ayoobi A, Lee S, et al
   A plant gallotannin pentagalloyl d-glucose elicits antiviral activity against influenza A and B viruses through multi-targeting mechanisms.
   Arch Virol. 2026;171:139.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

3. JACKSON C, Wijlaars L, Abdullahi F, Liu M, et al
   Paediatric infection hospital admissions in England before, during, and after the COVID-19 pandemic.
   Epidemiol Infect. 2026;154:e33.
   PubMed         Abstract available
   
   
4. TADA A, Otake S, Kusano T, Hoshino T, et al
   Clinical features and trends of severe paediatric group A streptococcal infections in Japan in the post-COVID-19 pandemic era.
   Epidemiol Infect. 2026;154:e35.
   PubMed         Abstract available
   
   

   
   J Gen Virol

5. CHIU HP, Yeo YY, Lai TY, Hung CT, et al
   SARS-CoV-2 Nsp15 facilitates immune evasion and viral replication by limiting multiple host innate immune pathways, including cGAS-STING.
   J Gen Virol. 2026;107.
   PubMed         Abstract available
   
   
6. AMARBAYASGALAN S, Takahashi T, Sugiura Y, Shimizu K, et al
   Bovine respiratory syncytial virus utilizes the human insulin-like growth factor 1 receptor in the late stages of infection.
   J Gen Virol. 2026;107.
   PubMed         Abstract available
   
   

   
   J Infect

7. MAZARAKIS N, Toh ZQ, Neal E, Nguyen C, et al
   Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.
   J Infect. 2026;92:106727.
   PubMed         Abstract available
   
   
8. ZHANG H, Kang Z, Zhang Y, Yang Y, et al
   Evolutionary dynamics and global spread of macrolide-resistant Bordetella pertussis during the post-pandemic pertussis resurgence.
   J Infect. 2026 Mar 7:106718. doi: 10.1016/j.jinf.2026.106718.
   PubMed         Abstract available
   
   

   
   J Virol

9. BUTH SA, Marin M, Zhang Y, Avinoam O, et al
   Cyclosporine A rescues the influenza virus fusion with IFITM3-expressing cells by relocating the restriction factor to intraluminal vesicles of multivesicular bodies.
   J Virol. 2026 Mar 25:e0204525. doi: 10.1128/jvi.02045.
   PubMed         Abstract available
   
   
10. KURYSHKO M, Luttermann C, Bayoumi M, Mostafa A, et al
    Host-specific functional evolution of seal influenza A virus NS1 protein following avian-to-seal transmission.
    J Virol. 2026 Mar 24:e0165025. doi: 10.1128/jvi.01650.
    PubMed         Abstract available
    
    
11. LI S, Liu DX
    Interaction of coronavirus E protein with BRD2 plays important regulatory roles in viral replication and induction of pro-inflammatory response.
    J Virol. 2026 Mar 3:e0220125. doi: 10.1128/jvi.02201.
    PubMed         Abstract available
    
    
12. NOORUZZAMAN M, Butt SL, Rani R, Ye C, et al
    The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection.
    J Virol. 2026 Feb 27:e0064425. doi: 10.1128/jvi.00644.
    PubMed         Abstract available
    
    
13. LIN S, Chen X, Luo M, Cui X, et al
    DIDS modulates VDAC1 oligomerization to suppress intrinsic apoptosis and attenuates in vitro and in vivo RSV infection.
    J Virol. 2026;100:e0220025.
    PubMed         Abstract available
    
    
14. YAO Q, Mahase V, Hou W, Cruz-Cosme R, et al
    Computational and experimental identification of potential neutralizing peptides derived from human ACE2 against SARS-CoV-2 infection.
    J Virol. 2026 Jan 30:e0146825. doi: 10.1128/jvi.01468.
    PubMed         Abstract available
    
    

    
    Lancet

15. JERNIGAN DB, Rivers CM
    Learning from swine influenza, Ebola virus disease, and Legionnaires' disease in 1976.
    Lancet. 2026 Mar 19:S0140-6736(26)00460-5. doi: 10.1016/S0140-6736(26)00460.
    PubMed        
    
    

    
    PLoS One

16. MA X
    Optimizing online teaching effectiveness in elementary education: Exploring multifaceted pathways based fsQCA analysis.
    PLoS One. 2026;21:e0345463.
    PubMed         Abstract available
    
    
17. ATAYA F, Alamro A, Alghamdi A, Fouad D, et al
    Identification of polyphenols as novel neuropilin-1 cendR pocket inhibitors to block SARS-CoV-2 entry and enhance variant resistance.
    PLoS One. 2026;21:e0345051.
    PubMed         Abstract available
    
    
18. MIKI M, Shimazu Y, Obara RD, Nagamine T, et al
    Assessment of a baloxavir marboxil treatment protocol for high pathogenicity avian influenza in Okinawa Rails, an endangered species endemic to Japan.
    PLoS One. 2026;21:e0345055.
    PubMed         Abstract available
    
    
19. MATTHYS A, Amelinck L, Smet A, Ysenbaert T, et al
    Internal gene segments from a mouse-adapted influenza B virus confer increased pathogenicity to mice.
    PLoS One. 2026;21:e0335324.
    PubMed         Abstract available
    
    
20. WANG L, Xia Y, Goh EH, Chen M, et al
    A smoothing and bootstrap-based framework for early outbreak detection.
    PLoS One. 2026;21:e0345088.
    PubMed         Abstract available
    
    
21. NUNES BP, Crochemore-Silva I, Mielke GI, Vidaletti LP, et al
    Social inequalities in the misbelief of chloroquine's protective effect against COVID-19: results from the EPICOVID-19 study in Brazil.
    PLoS One. 2026;21:e0341666.
    PubMed         Abstract available
    
    
22. FREITAS NL, Oliveira RD, Santos AKDS, Cunha-Filho M, et al
    Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients.
    PLoS One. 2026;21:e0345280.
    PubMed         Abstract available
    
    
23. CORONADO GD, Dickerson JF, Tsou MH, Shivaprakash N, et al
    Temporal and geographic analyses of colorectal cancer screening during and after the COVID-19 pandemic in a federally qualified health center.
    PLoS One. 2026;21:e0345248.
    PubMed         Abstract available
    
    
24. SUN X, Cappelleri JC, Lupton LL, Moran MM, et al
    Assessment of long COVID symptom burden in patients testing positive for SARS-CoV-2 at a nationwide retail pharmacy.
    PLoS One. 2026;21:e0345639.
    PubMed         Abstract available
    
    
25. CALANCIE L, Pan Y, Bassarab K, Stowers KC, et al
    Association between local food policy council coverage and longitudinal household food insufficiency during COVID-19, stratified by race, ethnicity, and income.
    PLoS One. 2026;21:e0345654.
    PubMed         Abstract available
    
    
26. DAGHER M, Abboud A, Saad GE, Itani R, et al
    Predictors of employment attrition in Lebanon during multifaceted crises: The role of chronic diseases - a national cross-sectional study.
    PLoS One. 2026;21:e0328028.
    PubMed         Abstract available
    
    
27. KAWABATA J, Goto K, Maeda M, Fukuda H, et al
    Comparison of post-discharge mortality and medical expenditures in COVID-19 patients according to mechanical ventilation and extracorporeal membrane oxygenation use: The LIFE study.
    PLoS One. 2026;21:e0345939.
    PubMed         Abstract available
    
    
28. SIRAPHATWONGKORN A, Methiyothin T, Onuean K, Chinnasarn K, et al
    Forecasting Thailand's mobility trends using Feature Engineered XGBoost for pandemic crisis movement management.
    PLoS One. 2026;21:e0345547.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

29. SMITH E, Blaabaek EH, Reimer D, Jaeger MM, et al
    Gender gaps in reading increase during unplanned and planned school closures.
    Proc Natl Acad Sci U S A. 2026;123:e2523152123.
    PubMed         Abstract available
    
    
30. BATRA H, Luo S, Saunders KO, Higgins JS, et al
    Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V(H)1-2-rearranging mouse models.
    Proc Natl Acad Sci U S A. 2026;123:e2537053123.
    PubMed         Abstract available
    
    
31. VRIENDS MBL, Moran E, Calvelo M, Hansen T, et al
    Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents.
    Proc Natl Acad Sci U S A. 2026;123:e2504045123.
    PubMed         Abstract available
    
    
32. BALAKRISHNAN K, Chakraborty S, Chiang C, Stratton CM, et al
    Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation.
    Proc Natl Acad Sci U S A. 2026;123:e2528398123.
    PubMed         Abstract available
    
    
33. KADAM RU, Juraszek J, Brandenburg B, Garg D, et al
    Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins.
    Proc Natl Acad Sci U S A. 2026;123:e2537533123.
    PubMed         Abstract available
    
    
34. HARIT A, Mor M, Yefet R, Izhaki-Tavor LS, et al
    Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization.
    Proc Natl Acad Sci U S A. 2026;123:e2523864123.
    PubMed         Abstract available
    
    
35. VENTURA PC, Dam Jeong Y, Litvinova M, Kummer AG, et al
    VIBES: A multiscale modeling approach integrating within-host and between-hosts dynamics in epidemics.
    Proc Natl Acad Sci U S A. 2026;123:e2523055123.
    PubMed         Abstract available
    
    

    
    Vaccine

36. FRAWLEY JE, Hutchens J, Wiley K, Mahimbo A, et al
    Uptake of Commonwealth funded influenza vaccines for Australian children aged 6-months to <5 years during the COVID-19 pandemic.
    Vaccine. 2026;79:128514.
    PubMed         Abstract available
    
    

    
    Virus Res

37. FERREIRO I, Hurtado J, Bruno A, Cristina J, et al
    On the brink of emergence: an evolutionary approach to Influenza A virus H5N1 isolated from humans.
    Virus Res. 2026 Mar 21:199717. doi: 10.1016/j.virusres.2026.199717.
    PubMed         Abstract available
    

Intensive #reassortment and frequent #intercontinental #transmission revealed by long-term genetic analysis of #H10 avian #influenza viruses in #Taiwan

 

ABSTRACT

H10 subtype avian influenza viruses primarily circulate among wild waterfowl but can occasionally infect mammals, including humans, and recent sporadic human cases have raised significant public health concerns. In this study, we sequenced and analysed 59 H10 subtype viruses isolated from wild birds in Taiwan. Results showed that all isolates were genetically distinct from human and other mammalian H10 subtype isolates. Taiwanese isolates exhibited high genetic diversity and could be categorized into 34 distinct genotypes, with each genotype circulating only in a single migratory season and not recurring during subsequent seasons. Additional analyses revealed that certain gene pools frequently circulate in the Pacific Rim, with evidence of North American lineage genes establishing long-term populations in Eurasia and vice versa. Although no characteristics indicative of mammalian adaptation was found in the Taiwanese isolates, temporal changes in the haemagglutinin cleavage site sequences were observed. This study provides a comprehensive overview of the evolutionary dynamics of H10 avian influenza viruses isolated from wild birds in Taiwan, emphasizing the complexity of intercontinental gene flow and viral reassortment. Currently, no consistent molecular markers indicating the impact of H10 avian influenza viruses on mammals or poultry have been identified. Notably, the observed changes in the haemagglutinin cleavage site sequences among Eurasian viruses suggest potential antigenic variations, indicating a need for further investigation into these changes. This potential highlights the necessity of ongoing surveillance to track the evolution and transmission dynamics of these viruses.

Source: Emerging Microbes and Infections, https://www.tandfonline.com/doi/full/10.1080/22221751.2025.2556794#abstract

____

Detection of a Novel #Gull-like Clade of Newcastle Disease Virus and #H3N8 Avian #Influenza Virus in the #Arctic Region of #Russia (Taimyr Peninsula)

Abstract

Wild waterbirds are circulating important RNA viruses, such as avian coronaviruses, avian astroviruses, avian influenza viruses, and avian paramyxoviruses. Waterbird migration routes cover vast territories both within and between continents. The breeding grounds of many species are in the Arctic, but research into this region is rare. This study reports the first Newcastle disease virus (NDV) detection in Arctic Russia. As a result of a five-year study (from 2019 to 2023) of avian paramyxoviruses and avian influenza viruses in wild waterbirds of the Taimyr Peninsula, whole-genome sequences of NDV and H3N8 were obtained. The resulting influenza virus isolate was phylogenetically related to viruses that circulated between 2021 and 2023 in Eurasia, Siberia, and Asia. All NDV sequences were obtained from the Herring gull, and other gull sequences formed a separate gull-like clade in the sub-genotype I.1.2.1, Class II. This may indirectly indicate that different NDV variants adapt to more host species than is commonly believed. Further surveillance of other gull species may help to test the hypothesis of putative gull-specific NDV lineage and better understand their role in the evolution and global spread of NDV.

Source: Viruses, https://www.mdpi.com/1999-4915/17/7/955

____